Prognostic value of serum vascular endothelial growth factor (VEGF) and plasma activity of matrix metalloproteinase (MMP) 2 and 9 in lymphoma-affected dogs (Englisch)
- Neue Suche nach: Gentilini, F.
- Neue Suche nach: Calzolari, C.
- Neue Suche nach: Turba, M. E.
- Neue Suche nach: Agnoli, C.
- Neue Suche nach: Fava, D.
- Neue Suche nach: Forni, M.
- Neue Suche nach: Bergamini, P. F.
- Neue Suche nach: Gentilini, F.
- Neue Suche nach: Calzolari, C.
- Neue Suche nach: Turba, M. E.
- Neue Suche nach: Agnoli, C.
- Neue Suche nach: Fava, D.
- Neue Suche nach: Forni, M.
- Neue Suche nach: Bergamini, P. F.
In:
LEUKEMIA RESEARCH -OXFORD-
;
29
, 11
;
1263-1269
;
2005
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Prognostic value of serum vascular endothelial growth factor (VEGF) and plasma activity of matrix metalloproteinase (MMP) 2 and 9 in lymphoma-affected dogs
-
Beteiligte:Gentilini, F. ( Autor:in ) / Calzolari, C. ( Autor:in ) / Turba, M. E. ( Autor:in ) / Agnoli, C. ( Autor:in ) / Fava, D. ( Autor:in ) / Forni, M. ( Autor:in ) / Bergamini, P. F. ( Autor:in )
-
Erschienen in:LEUKEMIA RESEARCH -OXFORD- ; 29, 11 ; 1263-1269
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2005
-
Format / Umfang:7 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.99419
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.99419 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 29, Ausgabe 11
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1235
-
ERK expands its empireGoldfarb, A. N. et al. | 2005
- 1237
-
The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosisGartel, A. L. et al. | 2005
- 1239
-
GATA1 mutations as clonal markers of minimal residual disease in acute megakaryoblastic leukemia of Down syndrome-a new tool with significant potential applicationsHitzler, J. / Zipursky, A. et al. | 2005
- 1241
-
Cytogenetic studies in children with Down syndrome and acute leukemiaValladares, A. / Palma-Padilla, V. / Mejia-Arangure, J. M. / Guevara-Yanez, R. / Lerma-Reyes, A. / Salamanca-Gomez, F. et al. | 2005
- 1247
-
De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemiaHsiao, H. H. / Ito, Y. / Sashida, G. / Ohyashiki, J. H. / Ohyashiki, K. et al. | 2005
- 1253
-
Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activityFlinn, I. W. / Byrd, J. C. / Bartlett, N. / Kipps, T. / Gribben, J. / Thomas, D. / Larson, R. A. / Rai, K. / Petric, R. / Ramon-Suerez, J. et al. | 2005
- 1259
-
Vitamin D2 analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndromeKoeffler, H. P. / Aslanian, N. / O'Kelly, J. et al. | 2005
- 1263
-
Prognostic value of serum vascular endothelial growth factor (VEGF) and plasma activity of matrix metalloproteinase (MMP) 2 and 9 in lymphoma-affected dogsGentilini, F. / Calzolari, C. / Turba, M. E. / Agnoli, C. / Fava, D. / Forni, M. / Bergamini, P. F. et al. | 2005
- 1271
-
Aberrant expression of tumor suppressor genes and their association with chimeric oncogenes in pediatric acute lymphoblastic leukemiaKustanovich, A. M. / Savitskaja, T. V. / Bydanov, O. I. / Belevtsev, M. V. / Potapnev, M. P. et al. | 2005
- 1277
-
Signaling capacity of FcgRII isoforms in B-CLL cellsGamberale, R. / Fernandez-Calotti, P. / Sanjurjo, J. / Arrossagaray, G. / Avalos, J. S. / Geffner, J. / Giordano, M. et al. | 2005
- 1285
-
Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoAMattii, L. / Azzara, A. / Fazzi, R. / Carulli, G. / Chimenti, M. / Cecconi, N. / Galimberti, S. / Petrini, M. et al. | 2005
- 1293
-
Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathwayMiranda, M. B. / Xu, H. / Torchia, J. A. / Johnson, D. E. et al. | 2005
- 1307
-
Interferon beta increases c-Myc proteolysis in mouse monocyte/macrophage leukemia cellsHu, X. / Bies, J. / Wolff, L. et al. | 2005
- 1315
-
A proapoptotic function of p21 in differentiating granulocytesGhanem, L. / Steinman, R. et al. | 2005
- 1325
-
CD39-associated high ATPase activity contribute to the loss of P2X7-mediated calcium response in LCL cellsNie, K. / Zheng, G. G. / Zhang, X. J. / Lin, Y. M. / Wang, L. / Li, G. / Song, Y. H. / Wu, K. F. et al. | 2005
- 1335
-
Increase in Ara-C cytotoxicity in the presence of valproate, a histone deacetylase inhibitor, is associated with the concurrent expression of cyclin D1 and p27Kip1 in acute myeloblastic leukemia cellsSiitonen, T. / Koistinen, P. / Savolainen, E. R. et al. | 2005
- 1343
-
Evaluation of Manisa propolis effect on leukemia cell line by telomerase activityGunduz, C. / Biray, C. / Kosova, B. / Yilmaz, B. / Eroglu, Z. / Sahin, F. / Omay, S. B. / Cogulu, O. et al. | 2005
- 1347
-
Establishment of a novel human B-CLL-like xenograft model in nude mouseLoisel, S. / Ster, K. L. / Quintin-Roue, I. / Pers, J. O. / Bordron, A. / Youinou, P. / Berthou, C. et al. | 2005
- 1353
-
GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndromePine, S. R. / Guo, Q. / Yin, C. / Jayabose, S. / Levendoglu-Tugal, O. / Ozkaynak, M. F. / Sandoval, C. et al. | 2005
- 1357
-
Absence of p21CIP1, p27KIP1 and p57KIP2 methylation in MDS and AMLBrakensiek, K. / Langer, F. / Kreipe, H. / Lehmann, U. et al. | 2005
- 1361
-
Primary pulmonary plasmacytoma involving bilateral lungs and marked hypergammaglobulinemia: Differentiation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissueNiitsu, N. / Kohri, M. / Hayama, M. / Nakamine, H. / Nakamura, N. / Bessho, M. / Higashihara, M. et al. | 2005
- 1365
-
CML patient with rare b2a3 (e13a3) variant of BCR-ABL transcript: Complete molecular response to imatinibMoravcova, J. / Rulcova, J. / Polak, J. / Zemanova, Z. / Klamova, H. / Haskovec, C. et al. | 2005
-
Editorial board and publication information| 2005